Starter kit for spectacle lenses
The Gen S lens starter kit, from Transitions Optical, equips professionals with tools and resources to help showcase, ex-perience, and educate patients about these new lenses. Eye care professionals interested in the Transitions Gen S starter kit can visit TransitionsPRO.com/GENS (one per practice) to place their order, while supplies last, according to a press release.
Ophthalmic instrument stand
The IS-6500, from Topcon Healthcare, is a digital instrument stand. It incorporates features that can be customized to allow the operator to control room lights, read lamp brightness, and binocular indirect retinoscopy brightness directly from its built-in touchscreen panel, according to a press release. Additionally, the stand features a redesigned slit lamp arm mechanism, allowing for single-handed adjustment. topconhealthcare.com/products/is-6500/
Artificial-intelligence powered smart glasses
Eye6 with Ivy, from Eyedaptic, is a wearable vision aid that both enhances vision and provides an artificial intelligence-powered visual assistant, according to a press release. The smart glasses feature Ivy, an interactive visual assistant meant to help individuals who have retinal disorders, such as age-related macular degeneration. eyedaptic.com/eyedaptic-unveilseye6/
Lubricating drops
Refresh Tears PF and Refresh Relieva PF Extra, from AbbVie, are preservative-free lubricant eye drops. The formula employs HydroCell technology that calls on a sodium chloride/salt-free glycerin-based solution to aid in hydration. The multidose bottle design is engineered with a soft-squeeze in mind and a double lockout system that keeps the drops sterile, according to a press release. www.abbvie.com/patients/products.html#refresh
Topical allergy medication
OCuSOFT Retaine Allergy olopatadine hydrochloride ophthalmic solution, USP 0.2% is a once-daily antihistamine therapy for the treatment of eye allergy itch relief. Each multidose bottle of the new formulation contains a 30-day supply. The drops are available through ocusoft.com.
Neovascular age-related macular degeneration drug
Sandoz received FDA approval for aflibercept-abzv (Enzeevu), a 2 mg vial kit and pre-filled syringe for intravitreal injection for the improvement and maintenance of visual acuity in patients who have neovascular age-related macular degeneration (AMD). This can now be part of your discussion with AMD patients to prepare them for their treatment options when speaking with their retina specialist. See full prescribing information here: bit.ly/SandozEnzeevu. OM